Georgios Ntentas1, Sarah C Darby2, Marianne C Aznar3, David C Hodgson4, Rebecca M Howell5, Maja V Maraldo6, Sameera Ahmed4, Angela Ng4, Berthe M P Aleman7, David J Cutter8. 1. Nuffield Department of Population Health, University of Oxford, Oxford, UK; Guy's and St Thomas' NHS Foundation Trust, Department of Medical Physics, London, UK. Electronic address: georgios.ntentas@ndph.ox.ac.uk. 2. Nuffield Department of Population Health, University of Oxford, Oxford, UK. 3. Nuffield Department of Population Health, University of Oxford, Oxford, UK; Manchester Cancer Research Centre, University of Manchester, UK. 4. Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto, Canada. 5. Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA. 6. Department of Clinical Oncology, Section of Radiotherapy, Rigshospitalet, Copenhagen University Hospital, Denmark. 7. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 8. Nuffield Department of Population Health, University of Oxford, Oxford, UK; Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Abstract
BACKGROUND AND PURPOSE: Radiation-related heart disease (RRHD) can occur many decades after thoracic radiotherapy for Hodgkin lymphoma (HL) or childhood cancer (CC). To quantify the likely risk of RRHD for patients treated today, dose-response relationships derived from patients treated in previous decades are used. Publications presenting these dose-response relationships usually include estimates of uncertainties in the risks but ignore the effect of uncertainties in the reconstructed cardiac doses. MATERIALS/ METHODS: We assessed the systematic and random uncertainties in the reconstructed doses for published dose-response relationships for RRHD risk in survivors of HL or CC. Using the same reconstruction methods as were used in the original publications, we reconstructed mean heart doses and, wherever possible, mean left-ventricular doses for an independent case-series of test patients. These patients had known, CT-based, cardiac doses which were compared with the reconstructed doses to estimate the magnitude of the uncertainties and their effect on the dose-response relationships. RESULTS: For all five reconstruction methods the relationship between reconstructed and CT-based doses was linear. For all but the simplest reconstruction method, the dose uncertainties were moderate, the effect of the systematic uncertainty on the dose-response relationships was less than 10%, and the effects of random uncertainty were small except at the highest doses. CONCLUSIONS: These results increase confidence in the published dose-response relationships for the risk of RRHD in HL and CC survivors. This may encourage doctors to use these dose-response relationships when estimating individualised risks for patients-an important aspect of personalising radiotherapy treatments today.
BACKGROUND AND PURPOSE:Radiation-related heart disease (RRHD) can occur many decades after thoracic radiotherapy for Hodgkin lymphoma (HL) or childhood cancer (CC). To quantify the likely risk of RRHD for patients treated today, dose-response relationships derived from patients treated in previous decades are used. Publications presenting these dose-response relationships usually include estimates of uncertainties in the risks but ignore the effect of uncertainties in the reconstructed cardiac doses. MATERIALS/ METHODS: We assessed the systematic and random uncertainties in the reconstructed doses for published dose-response relationships for RRHD risk in survivors of HL or CC. Using the same reconstruction methods as were used in the original publications, we reconstructed mean heart doses and, wherever possible, mean left-ventricular doses for an independent case-series of test patients. These patients had known, CT-based, cardiac doses which were compared with the reconstructed doses to estimate the magnitude of the uncertainties and their effect on the dose-response relationships. RESULTS: For all five reconstruction methods the relationship between reconstructed and CT-based doses was linear. For all but the simplest reconstruction method, the dose uncertainties were moderate, the effect of the systematic uncertainty on the dose-response relationships was less than 10%, and the effects of random uncertainty were small except at the highest doses. CONCLUSIONS: These results increase confidence in the published dose-response relationships for the risk of RRHD in HL and CC survivors. This may encourage doctors to use these dose-response relationships when estimating individualised risks for patients-an important aspect of personalising radiotherapy treatments today.
Authors: Frances K Duane; Naomi B Boekel; Judy N Jacobse; Zhe Wang; Berthe M P Aleman; Sarah C Darby; Michael Schaapveld; Flora E van Leeuwen; Margreet H A Baaijens; Samantha Warren; Carolyn W Taylor Journal: Clin Transl Radiat Oncol Date: 2022-07-16
Authors: Suman Shrestha; James E Bates; Qi Liu; Susan A Smith; Kevin C Oeffinger; Eric J Chow; Aashish C Gupta; Constance A Owens; Louis S Constine; Bradford S Hoppe; Wendy M Leisenring; Ying Qiao; Rita E Weathers; Laurence E Court; Chelsea C Pinnix; Stephen F Kry; Daniel A Mulrooney; Gregory T Armstrong; Yutaka Yasui; Rebecca M Howell Journal: Radiother Oncol Date: 2021-08-26 Impact factor: 6.901
Authors: Marjan Boerma; Catherine M Davis; Isabel L Jackson; Dörthe Schaue; Jacqueline P Williams Journal: Int J Radiat Biol Date: 2021-07-01 Impact factor: 2.694
Authors: Georgios Ntentas; Katerina Dedeckova; Michal Andrlik; Marianne C Aznar; Rebecca Shakir; Johanna Ramroth; Rubina Begum; Jiří Kubeš; Sarah C Darby; N George Mikhaeel; David J Cutter Journal: Int J Radiat Oncol Biol Phys Date: 2021-11-09 Impact factor: 7.038
Authors: David J Cutter; Johanna Ramroth; Patricia Diez; Andy Buckle; Georgios Ntentas; Bilyana Popova; Laura Clifton-Hadley; Peter J Hoskin; Sarah C Darby; John Radford; Tim Illidge Journal: J Clin Oncol Date: 2021-08-13 Impact factor: 50.717
Authors: Ziyuan Wang; Marco Virgolin; Brian V Balgobind; Irma W E M van Dijk; Susan A Smith; Rebecca M Howell; Matthew M Mille; Choonsik Lee; Choonik Lee; Cécile M Ronckers; Peter A N Bosman; Arjan Bel; Tanja Alderliesten Journal: Adv Radiat Oncol Date: 2022-07-04